Biotech startup uses tobacco plants to make vaccines

03/22/2012 | InnovationNewsDaily.com

U.S. biotech startup Inserogen has transformed tobacco plants into biological factories for manufacturing proteins for new vaccines and treatments. Using the SwiftVax tobacco plants, the startup is developing a vaccine for Newcastle disease, and a therapeutic protein for patients with alpha-1 antitrypsin deficiency. "The technology is easy to customize, and can be engineered to produce not only vaccines, but virtually any recombinant protein," Inserogen's Lucas Arzola said.

View Full Article in:

InnovationNewsDaily.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY